Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.

Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH.

J Gastrointest Surg. 2012 Sep;16(9):1696-704. doi: 10.1007/s11605-012-1912-8. Epub 2012 May 30.

2.

Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?

Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, Furukawa K, Takayasiki T, Kuboki S, Okamura D, Suzuki D, Nakajima M.

Surgery. 2014 Jan;155(1):58-66. doi: 10.1016/j.surg.2013.06.050. Epub 2013 Nov 12.

PMID:
24238124
3.

Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer.

Chang SC, Hsu CP, Tsai CY, Liu YY, Liu KH, Hsu JT, Yeh TS, Yeh CN, Hwang TL.

Medicine (Baltimore). 2016 Jul;95(30):e4191. doi: 10.1097/MD.0000000000004191.

4.

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.

Strobel O, Hartwig W, Hackert T, Hinz U, Berens V, Grenacher L, Bergmann F, Debus J, Jäger D, Büchler M, Werner J.

Ann Surg Oncol. 2013 Mar;20(3):964-72. doi: 10.1245/s10434-012-2762-z. Epub 2012 Dec 12.

PMID:
23233235
5.

Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.

Zhou Y, Song A, Wu L, Si X, Li Y.

Pancreatology. 2016 Nov - Dec;16(6):1124-1128. doi: 10.1016/j.pan.2016.09.015. Epub 2016 Sep 29. Review.

PMID:
27717684
6.

Surgery for recurrent pancreatic ductal adenocarcinoma.

Kleeff J, Reiser C, Hinz U, Bachmann J, Debus J, Jaeger D, Friess H, Büchler MW.

Ann Surg. 2007 Apr;245(4):566-72.

7.

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?

Buc E, Orry D, Antomarchi O, Gagnière J, Da Ines D, Pezet D.

World J Surg Oncol. 2014 Nov 18;12:347. doi: 10.1186/1477-7819-12-347.

8.

Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.

Yamashita K, Miyamoto A, Hama N, Asaoka T, Maeda S, Omiya H, Takami K, Doki Y, Mori M, Nakamori S.

Dig Surg. 2015;32(6):464-71. doi: 10.1159/000439545. Epub 2015 Oct 31.

PMID:
26517228
9.

Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.

Van den Broeck A, Sergeant G, Ectors N, Van Steenbergen W, Aerts R, Topal B.

Eur J Surg Oncol. 2009 Jun;35(6):600-4. doi: 10.1016/j.ejso.2008.12.006. Epub 2009 Jan 7.

PMID:
19131205
10.

Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns.

Wangjam T, Zhang Z, Zhou XC, Lyer L, Faisal F, Soares KC, Fishman E, Hruban RH, Herman JM, Laheru D, Weiss M, Li M, De Jesus-Acosta A, Wolfgang CL, Zheng L.

Oncotarget. 2015 Nov 3;6(34):36903-10. doi: 10.18632/oncotarget.5054.

11.

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.

Ann Surg. 2013 Apr;257(4):731-6. doi: 10.1097/SLA.0b013e318263da2f.

PMID:
22968073
12.

Resection of isolated local and metastatic recurrence in periampullary adenocarcinoma.

Boone BA, Zeh HJ, Mock BK, Johnson PJ, Dvorchik I, Lee K, Moser AJ, Bartlett DL, Marsh JW.

HPB (Oxford). 2014 Mar;16(3):197-203. doi: 10.1111/hpb.12119. Epub 2013 Apr 22.

14.

Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center.

Michalski CW, Kleeff J, Bachmann J, Alkhatib J, Erkan M, Esposito I, Hinz U, Friess H, Büchler MW.

Ann Surg Oncol. 2008 Jan;15(1):186-92. Epub 2007 Oct 18.

15.

Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.

Park JB, Kim YH, Kim J, Chang HM, Kim TW, Kim SC, Kim PN, Han DJ.

J Vasc Interv Radiol. 2012 May;23(5):635-41. doi: 10.1016/j.jvir.2012.01.080.

PMID:
22525021
16.

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG.

Gastroenterology. 2002 Nov;123(5):1500-7.

PMID:
12404225
17.

Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer.

Sugiura T, Uesaka K, Mihara K, Sasaki K, Kanemoto H, Mizuno T, Okamura Y.

Surgery. 2013 Nov;154(5):1078-86. doi: 10.1016/j.surg.2013.04.015. Epub 2013 Aug 22.

PMID:
23973112
18.

Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.

White R, D'Angelica M, Katabi N, Tang L, Klimstra D, Fong Y, Brennan M, Allen P.

J Am Coll Surg. 2007 May;204(5):987-93; discussion 993-5. Epub 2007 Mar 27.

PMID:
17481526
19.

Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case.

Akabori H, Shiomi H, Naka S, Murakami K, Murata S, Ishida M, Kurumi Y, Tani T.

World J Surg Oncol. 2014 Jul 18;12:224. doi: 10.1186/1477-7819-12-224.

20.

Patterns of Recurrence After Resection of IPMN: Who, When, and How?

Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Castillo CF.

Ann Surg. 2015 Dec;262(6):1108-14. doi: 10.1097/SLA.0000000000001008.

PMID:
25793719

Supplemental Content

Support Center